Improving Health From The Inside Out
The Farncombe Family Digestive Health Research Institute was established in 2008 replacing McMaster University’s Intestinal Disease Research Program that had been in existence since 1984. The Institute’s vision is to better understand and treat, and ultimately cure, the most common categories of intestinal illness that burden our society: inflammatory, functional and diet-induced disorders. The Institute pursues its vision by adopting an integrated multidisciplinary approach that encompasses bench-to-bedside research and involves close collaborations between clinicians, clinician-scientists and basic scientists. The vision also mandates the provision of the best possible experience that will enable our trainees to pursue successful careers in the academic and private sectors. Knowledge translation is a key aspect of our vision, serving to inform the public of advances in our understanding of digestive diseases, and to increase awareness of the burden of these diseases on our society.
According to a new study in Nature by Meisel and Hinterleitner et al, signals from the gut microbiota may help induce a pre-leukemic state in individuals with genetic predisposition. Mutations,...
Mike Surette has been elected to Fellowship in the American Academy of Microbiology. The Academy, the honorific leadership group within the American Society for Microbiology, recognizes...
As part of our commitment to knowledge dissemination and outreach on topics of GI health and disease, members such as Dr. Elena Verdu and her postdoc Heather Galipeau contribute regularly to Gut...
Maria Ines Pinto Sanchez has recently been awarded certification as a Certified Nutrition Support Clinician (CNSC) by the National Board of Nutrition Support Certification (NBNSC). She has...
The role of protein metabolism by bacteria in gastrointestinal inflammation
Dr. Alberto Caminero, Farncombe Institute
TOPIC: “The role of protein metabolism by bacteria in gastrointestinal inflammation”
OBJECTIVES: At the end of the session, participants should be able to:
1. Understand how the metabolism of dietary proteins and amino acids by intestinal microbiota can influence gastrointestinal disorders
2. Review the physiopathological consequences of microbiota amino acid metabolism in relation to IBD
3. Discuss the rationale behind the use of dietary intervention and microbiota targeted therapies to treat GI conditions
This event is an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.